Close
Solutions
Online Inquiry
Global Services

CAR Modified T Cells

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Creative Biolabs offers CellRapeutics™ Chimeric Antigen Receptor (CAR) production service with the highest quality. As a leading service provider, our experienced scientists are glad to provide highly customized, reliable and effective solutions for our customers.

T cells play a critical role in cell-mediated immunity, which can attack and kill cancer cells. However, cancer cells can usually avoid being attacked by T cells via a series of defense mechanisms. Recently, genetically modified T cell immunotherapy which targets tumor via directly recognizing tumor associated antigen, has become one of the most attractive approaches for treating various cancers.

A classic CAR molecule usually composes of a single chain antibody (scFv) domain, a transmembrane domain and cytoplasmic signaling domains. After the CAR-T cells being infused back into cancer patients, these modified T cells can directly recognize and kill the cancer cells which display tumor specific antigens. Experts from Creative Biolabs have successfully established cutting-edge CARs T cells construction platform, which can fit your application purpose according to the requirement.

Creative Biolabs has rich experience in developing CARs. Our skilled scientists and technicians guarantee that we can offer you unparalleled CARs-T cell construction services.

CAR Modified T cells

Fred Hutchinson Cancer Research Center website and Turtle CJ, Hudecek M, Jensen MC, Riddell SR. Engineered T cells for anti-cancer therapy. Curr Opin Immunol. 2012 Oct; 24(5):633-9.

Online Inquiry

For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.